Non Alcoholic Fatty Liver Disease (NAFLD) Market - Pipeline Insight Report 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2019 report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Non Alcoholic Fatty Liver Disease (NAFLD) development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

The report assesses the active Non Alcoholic Fatty Liver Disease (NAFLD) pipeline products by developmental stage, product type, molecule type, and administration route.

Key Topics Covered:

1. Report Introduction

2. Non Alcoholic Fatty Liver Disease (NAFLD) Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Non Alcoholic Fatty Liver Disease (NAFLD)

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products
8.1 Drug Name : Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Mentioned (Partial List)

  • Allergan Plc
  • Arisaph Pharmaceuticals Inc
  • AstraZeneca Plc
  • Betagenon AB
  • Bird Rock Bio Inc
  • Can-Fite BioPharma Ltd
  • Cerenis Therapeutics Holding SA
  • Conatus Pharmaceuticals Inc
  • CymaBay Therapeutics Inc
  • Daewoong Pharmaceutical Co Ltd

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/rmb9lk/non_alcoholic?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Liver and Kidney Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Liver and Kidney Disorders Drugs